BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 31197036)

  • 1. Enhanced acetylation of ATP-citrate lyase promotes the progression of nonalcoholic fatty liver disease.
    Guo L; Guo YY; Li BY; Peng WQ; Chang XX; Gao X; Tang QQ
    J Biol Chem; 2019 Aug; 294(31):11805-11816. PubMed ID: 31197036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth.
    Lin R; Tao R; Gao X; Li T; Zhou X; Guan KL; Xiong Y; Lei QY
    Mol Cell; 2013 Aug; 51(4):506-518. PubMed ID: 23932781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylation of Mitochondrial Trifunctional Protein α-Subunit Enhances Its Stability To Promote Fatty Acid Oxidation and Is Decreased in Nonalcoholic Fatty Liver Disease.
    Guo L; Zhou SR; Wei XB; Liu Y; Chang XX; Liu Y; Ge X; Dou X; Huang HY; Qian SW; Li X; Lei QY; Gao X; Tang QQ
    Mol Cell Biol; 2016 Oct; 36(20):2553-67. PubMed ID: 27457618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Steatotic Cells, ATP-Citrate Lyase mRNA Is Efficiently Translated through a Cap-Independent Mechanism, Contributing to the Stimulation of De Novo Lipogenesis.
    Siculella L; Giannotti L; Testini M; Gnoni GV; Damiano F
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bempedoic Acid Unveils Therapeutic Potential in Non-Alcoholic Fatty Liver Disease: Suppression of the Hepatic PXR-SLC13A5/ACLY Signaling Axis.
    Sun Q; Guo Y; Hu W; Zhang M; Wang S; Lei Y; Meng H; Li N; Xu P; Li Z; Lin H; Huang F; Qiu Z
    Drug Metab Dispos; 2023 Dec; 51(12):1628-1641. PubMed ID: 37684055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hrd1-mediated ACLY ubiquitination alleviate NAFLD in db/db mice.
    Li K; Zhang K; Wang H; Wu Y; Chen N; Chen J; Qiu C; Cai P; Li M; Liang X; Su D
    Metabolism; 2021 Jan; 114():154349. PubMed ID: 32888949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirtuin 2 Prevents Liver Steatosis and Metabolic Disorders by Deacetylation of Hepatocyte Nuclear Factor 4α.
    Ren H; Hu F; Wang D; Kang X; Feng X; Zhang L; Zhou B; Liu S; Yuan G
    Hepatology; 2021 Aug; 74(2):723-740. PubMed ID: 33636024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation on Citrate Influx and Metabolism through Inhibiting SLC13A5 and ACLY: A Novel Mechanism Mediating the Therapeutic Effects of Curcumin on NAFLD.
    Sun Q; Niu Q; Guo Y; Zhuang Y; Li X; Liu J; Li N; Li Z; Huang F; Qiu Z
    J Agric Food Chem; 2021 Aug; 69(31):8714-8725. PubMed ID: 34323067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice.
    Wang Q; Jiang L; Wang J; Li S; Yu Y; You J; Zeng R; Gao X; Rui L; Li W; Liu Y
    Hepatology; 2009 Apr; 49(4):1166-75. PubMed ID: 19177596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical activation of transcription factor SREBP1c and de novo lipogenesis by hepatocyte-selective ATP-citrate lyase depletion in obese mice.
    Yenilmez B; Kelly M; Zhang GF; Wetoska N; Ilkayeva OR; Min K; Rowland L; DiMarzio C; He W; Raymond N; Lifshitz L; Pan M; Han X; Xie J; Friedline RH; Kim JK; Gao G; Herman MA; Newgard CB; Czech MP
    J Biol Chem; 2022 Oct; 298(10):102401. PubMed ID: 35988648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP Citrate Lyase and LncRNA NONMMUT010685 Play Crucial Role in Nonalcoholic Fatty Liver Disease Based on Analysis of Microarray Data.
    Ma TT; Huang C; Ni Y; Yang Y; Li J
    Cell Physiol Biochem; 2018; 51(2):871-885. PubMed ID: 30466110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells.
    Migita T; Okabe S; Ikeda K; Igarashi S; Sugawara S; Tomida A; Soga T; Taguchi R; Seimiya H
    Int J Cancer; 2014 Jul; 135(1):37-47. PubMed ID: 24310723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100A11 Promotes Liver Steatosis via FOXO1-Mediated Autophagy and Lipogenesis.
    Zhang L; Zhang Z; Li C; Zhu T; Gao J; Zhou H; Zheng Y; Chang Q; Wang M; Wu J; Ran L; Wu Y; Miao H; Zou X; Liang B
    Cell Mol Gastroenterol Hepatol; 2021; 11(3):697-724. PubMed ID: 33075563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitination of PPAR-gamma by pVHL inhibits ACLY expression and lipid metabolism, is implicated in tumor progression.
    Noh KH; Kang HM; Yoo W; Min Y; Kim D; Kim M; Wang S; Lim JH; Jung CR
    Metabolism; 2020 Sep; 110():154302. PubMed ID: 32589900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIRT2 Deficiency Aggravates Diet-Induced Nonalcoholic Fatty Liver Disease through Modulating Gut Microbiota and Metabolites.
    Li X; Du Y; Xue C; Kang X; Sun C; Peng H; Fang L; Han Y; Xu X; Zhao C
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LY6D is crucial for lipid accumulation and inflammation in nonalcoholic fatty liver disease.
    Lee J; Kim H; Kang YW; Kim Y; Park MY; Song JH; Jo Y; Dao T; Ryu D; Lee J; Oh CM; Park S
    Exp Mol Med; 2023 Jul; 55(7):1479-1491. PubMed ID: 37394588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian SIRT6 Represses Invasive Cancer Cell Phenotypes through ATP Citrate Lyase (ACLY)-Dependent Histone Acetylation.
    Zheng W; Tasselli L; Li TM; Chua KF
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIRT2 Deficiency Exacerbates Hepatic Steatosis via a Putative Role of the ER Stress Pathway.
    Leal H; Cardoso J; Valério P; Quatorze M; Carmona V; Cunha-Santos J; Pereira de Almeida L; Pereira C; Cavadas C; Gomes P
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic Switch.
    Zhao S; Torres A; Henry RA; Trefely S; Wallace M; Lee JV; Carrer A; Sengupta A; Campbell SL; Kuo YM; Frey AJ; Meurs N; Viola JM; Blair IA; Weljie AM; Metallo CM; Snyder NW; Andrews AJ; Wellen KE
    Cell Rep; 2016 Oct; 17(4):1037-1052. PubMed ID: 27760311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP citrate lyase knockdown induces growth arrest and apoptosis through different cell- and environment-dependent mechanisms.
    Zaidi N; Royaux I; Swinnen JV; Smans K
    Mol Cancer Ther; 2012 Sep; 11(9):1925-35. PubMed ID: 22718913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.